Get Live Data
Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share Regulatory News
  5. Total Voting Rights

Pin to quick picksGlaxosmithkline Regulatory News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,766.50
Bid: 1,766.00
Ask: 1,766.50
Change: 36.50 (2.11%)
Spread: 0.50 (0.028%)
Open: 1,735.50
High: 1,766.50
Low: 1,735.00
Prev. Close: 1,730.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

1 Oct 2018 13:58

RNS Number : 5611C
GlaxoSmithKline PLC
01 October 2018
 

GlaxoSmithKline plc

 

Total Voting Rights and Capital

 

In conformity with the Financial Conduct Authority's Disclosure Guidance and Transparency Rule 5.6.1R, GlaxoSmithKline plc (the 'Company') hereby notifies the market of the following:

 

The Company's issued share capital as at 30 September 2018 consisted of 5,375,085,545 shares of 25 pence each ('Ordinary Shares'), of which 414,605,950 Ordinary Shares were held in Treasury.

 

Therefore, the total number of voting rights in the Company is 4,960,479,595. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

 

 

 

V A Whyte

Company Secretary

 

1 October 2018

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRUGGMAUUPRGPG
121314151617181920
Date   Source Headline
29th Jul 20197:00 amRNSViiV submits cabotegravir to EMA for HIV injection
24th Jul 20196:01 pmRNSDirector/PDMR Shareholding
24th Jul 20194:01 pmRNSViiV 2DR TANGO switch study positive at 48 weeks
24th Jul 20194:00 pmRNSViiV GEMINI studies show high efficacy at 96 weeks
24th Jul 201912:07 pmRNSSecond Price Monitoring Extn
24th Jul 201912:02 pmRNSPrice Monitoring Extension
24th Jul 201912:00 pmRNS2nd Quarter Results
24th Jul 201910:00 amRNSNon-Executive Chairman
22nd Jul 20195:00 pmRNSViiV presents 96-week data from phase III study
15th Jul 20196:19 pmRNSDirector/PDMR Shareholding
15th Jul 20196:18 pmRNSDirector/PDMR Shareholding
15th Jul 20196:16 pmRNSDirector/PDMR Shareholding
15th Jul 201911:42 amRNSDirector/PDMR Shareholding
15th Jul 20197:00 amRNSpositive results in Phase 3 PRIMA study of ZEJULA
12th Jul 20194:35 pmRNSDirector/PDMR Shareholding
12th Jul 20193:55 pmRNSDirector/PDMR Shareholding
10th Jul 20193:48 pmRNSDirector/PDMR Shareholding
10th Jul 20197:00 amRNSViiV switch study shows 2DR as effective as 3DR
1st Jul 201912:08 pmRNSTotal Voting Rights
12th Jun 20195:10 pmRNSDirector/PDMR Shareholding
7th Jun 20197:00 amRNSFDA approval for Nucala self-administration
4th Jun 20198:00 amRNSCHMP positive on GSK's Nucala self-administration
3rd Jun 20192:31 pmRNSTotal Voting Rights
24th May 201910:54 amRNSDirector/PDMR Shareholding
20th May 20191:44 pmRNSDirector/PDMR Shareholding
13th May 20195:44 pmRNSBlock listing Interim Review
13th May 20194:19 pmRNSDirector/PDMR Shareholding
8th May 20196:23 pmRNSResult of AGM & GM
2nd May 20195:07 pmRNSTrelegy Ellipta asthma study met primary endpoint
1st May 20193:11 pmRNSDirector/PDMR Shareholding
1st May 20192:32 pmRNSTotal Voting Rights
1st May 201912:00 pmRNS1st Quarter Results
29th Apr 201912:00 pmRNSViiV submits NDA for HIV monthly 2 drug injectable
26th Apr 20194:16 pmRNSViiV receives CHMP Positive Opinion for Dovato
16th Apr 20195:36 pmRNSDirector/PDMR Shareholding
16th Apr 20195:35 pmRNSDirector/PDMR Shareholding
16th Apr 20195:23 pmRNSDirector/PDMR Shareholding
16th Apr 20195:14 pmRNSDirector/PDMR Shareholding
15th Apr 20192:45 pmRNSDirector/PDMR Shareholding
12th Apr 20194:47 pmRNSDirector/PDMR Shareholding
12th Apr 20194:33 pmRNSDirector/PDMR Shareholding
11th Apr 20195:01 pmRNSDirector/PDMR Shareholding
9th Apr 20197:00 amRNSFDA approves ViiV's two-drug HIV regimen, Dovato
2nd Apr 20191:00 pmRNSPublication of AGM and GM Shareholder Documents
1st Apr 20194:36 pmRNSTotal Voting Rights
28th Mar 20194:15 pmRNSGSK reporting changes - product sales and IFRS 16
25th Mar 20195:02 pmRNSDirector/PDMR Shareholding
21st Mar 20194:00 pmRNSGSK announces further positive data from DREAMM-1
19th Mar 20195:45 pmRNSData from GARNET study evaluating dostarlimab
18th Mar 20197:00 amRNSGSK Annual Report 2018 on Form 20-F
121314151617181920

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.